News

< Back

Grantees in the News: AFAR Grantees Weigh-in on Longevity-Extending Drugs

On October 2nd, 2014, The Independent sited two distinguished AFAR grantees: AFAR’s Deputy Scientific Director and two-time grant award recipient, Nir Barzilai, M.D., and 2003 AFAR Research Award and 2008 Julie Martin Mid-Career Award in Aging Research recipient, Brian Kennedy, Ph.D.

Dr. Barzilai and Dr. Kennedy commented on three drugs that have already been approved for human use for various ailments and have improved immunity response and increased lifespan in animal models. For example, the type 2 diabetes medicine Metformin has been shown to extend the average lifespan of small animals by 5 percent and is believed to be safe and ready for human testing.

If Dr. Barzilai and Dr. Kennedy’s predictions are correct, there may be drugs already on the market that can postpone or decrease some of the health related decline associated with old age.

Dr. Nir Barzilai is a Professor in the Albert Einstein College of Medicine Departments of Medicine and Genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and the Director of the college’s Institute for Aging Research.

Dr. Brian Kennedy is the President and CEO of the Buck Institute for Research on Aging.

For further insights on longevity and theories of aging, visit AFAR’s online resource, InfoAging.org.

More Recent News

View All News >
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research.
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research.
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature.
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature.
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Norman Volk, Former AFAR Board Member
In Memoriam: Norman Volk, Former AFAR Board Member
AFAR Grantee in the News: New Research by AFAR Grantee Aditi Gurkar on the molecular index of biological aging published in Aging Cell.
AFAR Grantee in the News: New Research by AFAR Grantee Aditi Gurkar on the molecular index of biological aging published in Aging Cell.
AFAR Grantee in the News: New Research by Dibyadeep Datta on a biomarker that could indicate ensuing Alzheimer's disease published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
AFAR Grantee in the News: New Research by Dibyadeep Datta on a biomarker that could indicate ensuing Alzheimer's disease published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
AFAR Grantee in the News: New Research by Mark E. Kleinman on histone dynamics, cellular senescence, and aging in Aging Cell.
AFAR Grantee in the News: New Research by Mark E. Kleinman on histone dynamics, cellular senescence, and aging in Aging Cell.
AFAR News: Gareth W. Shepherd, PhD, and Robert W. Stearns elected to Board of Directors
AFAR News: Gareth W. Shepherd, PhD, and Robert W. Stearns elected to Board of Directors